Abstract: An abuse deterrent and misuse deterrent transdermal patch comprising aversive agents incorporated in the backing layer of the patch. The aversive agents can exhibit biphasic or sustained kinetics of release with an immediate portion released rapidly and an extended portion released in a prolonged manner when exposed to a dissolution medium. The prolonged aversive agent release provides deterrence against extraction of drug from fresh and used patches and serves to prevent accidental misuse of used patches by children. The abuse deterrent and misuse deterrent patch systems can be used for transdermal delivery of therapeutically active agents and particularly those drugs that are highly prone to abuse such as opiate and opioid analgesics and stimulants.
Type:
Grant
Filed:
September 18, 2023
Date of Patent:
June 3, 2025
Assignee:
NUTRIBAND, INC.
Inventors:
David James Enscore, Frank Tagliaferri, Steven Paul Damon, Alan Smith, Jeffrey C. Gaulding
Abstract: An abuse deterrent and misuse deterrent transdermal patch comprising aversive agents incorporated in the backing layer of the patch. The aversive agents can exhibit biphasic or sustained kinetics of release with an immediate portion released rapidly and an extended portion released in a prolonged manner when exposed to a dissolution medium. The prolonged aversive agent release provides deterrence against extraction of drug from fresh and used patches and serves to prevent accidental misuse of used patches by children. The abuse deterrent and misuse deterrent patch systems can be used for transdermal delivery of therapeutically active agents and particularly those drugs that are highly prone to abuse such as opiate and opioid analgesics and stimulants.
Type:
Grant
Filed:
January 5, 2022
Date of Patent:
September 19, 2023
Assignee:
NUTRIBAND, INC.
Inventors:
David James Enscore, Frank Tagliaferri, Steven Paul Damon, Alan Smith, Jeffrey C. Gaulding
Abstract: An abuse deterrent and misuse deterrent transdermal patch comprising aversive agents incorporated in the backing layer of the patch. The aversive agents can exhibit biphasic or sustained kinetics of release with an immediate portion released rapidly and an extended portion released in a prolonged manner when exposed to a dissolution medium. The prolonged aversive agent release provides deterrence against extraction of drug from fresh and used patches and serves to prevent accidental misuse of used patches by children. The abuse deterrent and misuse deterrent patch systems can be used for transdermal delivery of therapeutically active agents and particularly those drugs that are highly prone to abuse such as opiate and opioid analgesics and stimulants.
Type:
Grant
Filed:
December 9, 2019
Date of Patent:
February 15, 2022
Assignee:
NUTRIBAND, INC.
Inventors:
David James Enscore, Frank Tagliaferri, Steven Paul Damon, Alan Smith, Jeffrey C. Gaulding